Table 3.
Outcome of treatment – compliance and relapse
| Treatment | No. (%) patients | No. (%) of patients who completed treatment | No. (%) of relapse |
|---|---|---|---|
| SAG | 89 (31.56) | 13 (14.61) | - |
| SAG + Allopurinol | 56 (19.86) | 10 (17.85) | - |
| SAG + Rifampicin | 9 (3.19) | 2 (22.23) | Not followed |
| SAG + Allopurinol + Rifampicin | 6 (2.12) | 0 (0) | - |
| SAG + Mw Vaccine | 8 (2.83) | 2 (25) | - |
| Miltefosine | 107 (37.94) | 91 (85.05) | 12 (13.18) |
| Amphotericin B | 1 (0.35) | 1 (100) | - |
| Miltefosine + Amphotericin B | 6 (2.12) | 5 (83.33) | - |
| Total | 282 | 124 (43.97) | 12 (9.67) |